Mangoceuticals Cash Flow Statement 2021-2024 | MGRX

Fifteen years of historical annual cash flow statements for Mangoceuticals (MGRX).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021
$-9.21$-2.00$0.00
$0.02$0.00$0.00
$2.15$0.43$0
$2.18$0.43$0
$0$0$0
$-0.02$0$0
$0$0$0
$-0.05$0.19$0
$0.04$0.22$0.00
$-7.00$-1.35$0.00
$0.00$-0.04$0.00
$0$0$0
$0$0$0.00
$0$0$0
$0$0$0
$0$0$0.00
$0$0$0
$0.00$-0.04$0.00
$0$0$0
$-0.17$0.05$0.00
$-0.17$0.05$0.00
$7.22$2.00$0
$7.22$2.00$0.00
$0$0$0.00
$0$0$0
$7.06$2.05$0.00
$0.06$0.66$0.00
$1.53$0.54$0
$0$0$0